Brief: Richter Announces FY Pharma Sales HUF 914 Billion
27/02/2026 05:12
Feb 27 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU: RICHTER - FY PHARMA SALES HUF 914 BILLION RICHTER - FY EBIT HUF 292.85 BILLION RICHTER - FY REVENUE HUF 928,962 MILLION RICHTER - 2026 GUIDANCE: HIGH-SINGLE-DIGIT (HSD) GROWTH BOTH REVENUES AND CLEAN EBIT (BOTH CER) RICHTER - FY REVENUE HUF 928.96 BILLION Source text: https://tinyurl.com/msn742a4 Further company coverage: GDRB.BU ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gedeon Richter
See all newsBrief: Hungary's Richter says US FDA accepted for review its new drug application for Fylrevy
Brief: Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth
development partnership in Tirzepatide
AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection